Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Ultragenyx Pharmaceutical (RARE) Return on Invested Capital: 2018-2024

Historic Return on Invested Capital for Ultragenyx Pharmaceutical (RARE) over the last 1 years, with Sep 2024 value amounting to -1.37%.

  • Ultragenyx Pharmaceutical's Return on Invested Capital was N/A to -1.37% in Q3 2024 from the same period last year, while for Sep 2024 it was -1.37%, marking a year-over-year change of. This contributed to the annual value of -1.81% for FY2023, which is N/A change from last year.
  • Per Ultragenyx Pharmaceutical's latest filing, its Return on Invested Capital stood at -1.37% for Q3 2024, which was up 28.32% from -1.91% recorded in Q2 2024.
  • In the past 5 years, Ultragenyx Pharmaceutical's Return on Invested Capital registered a high of -1.37% during Q3 2024, and its lowest value of -3.70% during Q4 2023.
  • Its 2-year average for Return on Invested Capital is -2.44%, with a median of -2.35% in 2024.